These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9663703)

  • 21. Interactions between thrombolytic agents and platelets: effects of plasmin on platelet glycoproteins Ib and IIb/IIIa.
    Hoffmann JJ; Janssen WC
    Thromb Res; 1992 Sep; 67(6):711-9. PubMed ID: 1440536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
    Azzam K; Cissé-Thiam M; Drouet L
    Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs.
    De Meyer SF; Vanhoorelbeke K; Ulrichts H; Staelens S; Feys HB; Salles I; Fontayne A; Deckmyn H
    Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):191-207. PubMed ID: 17017902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates.
    Terres W; Umnus S; Mathey DG; Bleifeld W
    Cardiovasc Res; 1990 Jun; 24(6):471-7. PubMed ID: 2167173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs.
    Vanhoorelbeke K; Ulrichts H; Schoolmeester A; Deckmyn H
    Curr Drug Targets Cardiovasc Haematol Disord; 2003 Jun; 3(2):125-40. PubMed ID: 12769639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions.
    Harsfalvi J; Stassen JM; Hoylaerts MF; Van Houtte E; Sawyer RT; Vermylen J; Deckmyn H
    Blood; 1995 Feb; 85(3):705-11. PubMed ID: 7833474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of platelet GPIIB-IIIA (Integrin alphaII(b)beta(3)) in flowing human blood leads to passivation of prothrombotic surfaces.
    Riederer MA; Ginsberg MH; Steiner B
    Thromb Haemost; 2002 Nov; 88(5):858-64. PubMed ID: 12428106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
    Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
    Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.
    Sakariassen KS; Nievelstein PF; Coller BS; Sixma JJ
    Br J Haematol; 1986 Aug; 63(4):681-91. PubMed ID: 2942171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a VWF peptide antagonist that blocks platelet adhesion under high shear conditions by selectively inhibiting the VWF-collagen interaction.
    Szanto T; Vanhoorelbeke K; Toth G; Vandenbulcke A; Toth J; Noppe W; Deckmyn H; Harsfalvi J
    J Thromb Haemost; 2009 Oct; 7(10):1680-7. PubMed ID: 19624458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of the roles of glycoprotein Ib and glycoprotein IIb/IIIa in platelet deposition on an artificial surface using clinical antiplatelet agents and monoclonal antibody blockade.
    Sheppeck RA; Bentz M; Dickson C; Hribar S; White J; Janosky J; Berceli SA; Borovetz HS; Johnson PC
    Blood; 1991 Aug; 78(3):673-80. PubMed ID: 1859882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions.
    Díaz-Ricart M; Estebanell E; Lozano M; Aznar-Salatti J; White JG; Ordinas A; Escolar G
    Haematologica; 2000 Mar; 85(3):280-8. PubMed ID: 10702817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions.
    Steiner M; Li W
    J Nutr; 2001 Mar; 131(3s):980S-4S. PubMed ID: 11238801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.